Matthew W. Emmens
2012
In 2012, Matthew W. Emmens earned a total compensation of $6.9M as Former Chairman, President CEO at Vertex Pharmaceuticals, a 48% decrease compared to previous year.
Compensation breakdown
| Option Awards | $4,612,290 |
|---|---|
| Salary | $467,514 |
| Stock Awards | $1,786,558 |
| Other | $29,667 |
| Total | $6,896,029 |
Emmens received $4.6M in option awards, accounting for 67% of the total pay in 2012.
Emmens also received $467.5K in salary, $1.8M in stock awards and $29.7K in other compensation.
Rankings
In 2012, Matthew W. Emmens' compensation ranked 792nd out of 11,487 executives tracked by ExecPay. In other words, Emmens earned more than 93.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 792 out of 11,487 | 93rd |
Division Manufacturing | 288 out of 4,253 | 93rd |
Major group Chemicals And Allied Products | 63 out of 1,198 | 95th |
Industry group Drugs | 34 out of 920 | 96th |
Industry Pharmaceutical Preparations | 30 out of 700 | 96th |
Source: SEC filing on April 4, 2013.
Emmens' colleagues
We found six more compensation records of executives who worked with Matthew W. Emmens at Vertex Pharmaceuticals in 2012.
2012
Jeffrey Leiden
Vertex Pharmaceuticals
Chief Executive Officer
2012
Stuart Arbuckle
Vertex Pharmaceuticals
EVP & Chief Commercial Officer
2012
Peter Mueller
Vertex Pharmaceuticals
Chief Scientific Officer
2012
David Howton
Vertex Pharmaceuticals
Chief Legal Officer
2012
Ian Smith
Vertex Pharmaceuticals
Chief Financial Officer
2012
Kenneth Horton
Vertex Pharmaceuticals